36 employees
Blaze Bioscience develops and commercializes products that assist surgeons to treat cancer patients.
2010
$16M
from 3 investors over 3 rounds
Blaze Bioscience raised $16M on October 12, 2017
Investors: Keiretsu Forum / Capital and Keiretsu Capital
Blaze Bioscience raised undisclosed on April 22, 2016
Investors: Keiretsu Capital